Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TAU PATHOLOGY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TAU PATHOLOGY is a concept in neurodegeneration research. Key relationships include: activates, biomarker for, therapeutic target. Associated with ALS, Aging, Als. Connected to 600 entities in the SciDEX knowledge graph.
No AI portrait yet
Knowledge base pages for this entity
graph TD
TAU_PATHOLOGY["TAU PATHOLOGY"]
TAU_PATHOLOGY -->|"activates"| neurodegeneration["neurodegeneration"]
TAU_PATHOLOGY -->|"causes"| synapse_loss["synapse loss"]
TAU_PATHOLOGY -->|"causes"| Alzheimer_s_disease["Alzheimer's disease"]
TAU_PATHOLOGY -->|"activates"| inflammatory_responses["inflammatory responses"]
TAU_PATHOLOGY -->|"activates"| neuroinflammation["neuroinflammation"]
TAU_PATHOLOGY -.protects against.-> Alzheimer["Alzheimer"]
autophagy_dysfunction["autophagy dysfunction"] -->|"activates"| TAU_PATHOLOGY
necroptosis["necroptosis"] -->|"activates"| TAU_PATHOLOGY
MHC_I["MHC-I"] -->|"activates"| TAU_PATHOLOGY
APOE["APOE"] -->|"regulates"| TAU_PATHOLOGY
ApoE4["ApoE4"] -->|"contributes to"| TAU_PATHOLOGY
TREM2["TREM2"] -->|"regulates"| TAU_PATHOLOGY
APOE3["APOE3"] -->|"regulates"| TAU_PATHOLOGY| Target | Relation | Type | Str |
|---|---|---|---|
| Neurodegeneration | associated_with | disease | 1.00 |
| Alzheimer | therapeutic_target | disease | 1.00 |
| neurodegeneration | activates | process | 1.00 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 1.00 |
| Alzheimer | biomarker_for | disease | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Alzheimer | regulates | disease | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Aging | associated_with | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| Als | biomarker_for | disease | 1.00 |
| MICROGLIA | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| ALZHEIMER'S DISEASE | activates | gene | 1.00 |
| Inflammation | regulates | disease | 0.95 |
| Alzheimer's Disease | involved_in | disease | 0.95 |
| Als | activates | disease | 0.95 |
| Neuroinflammation | regulates | disease | 0.95 |
| Alzheimer | protects_against | disease | 0.95 |
| Neurodegeneration | inhibits | disease | 0.95 |
| Aging | therapeutic_target | disease | 0.95 |
| Neurodegeneration | regulates | disease | 0.95 |
| Als | therapeutic_target | disease | 0.95 |
| Aging | activates | disease | 0.95 |
| Alzheimer'S Disease | biomarker_for | disease | 0.95 |
| Alzheimer's Disease | contributes_to | disease | 0.95 |
| Alzheimer's Disease | associated_with | disease | 0.95 |
| Behavior Variant Frontotemporal Dementia | involved_in | disease | 0.92 |
| Alzheimer'S | biomarker_for | disease | 0.92 |
| Neurodegeneration | causes | process | 0.90 |
| mitochondrial dysfunction | causes | process | 0.90 |
| Necroptosis | associated_with | process | 0.90 |
| Cognitive Decline | causes | phenotype | 0.90 |
| Alzheimer Disease | involved_in | disease | 0.90 |
| A1R | upregulates | protein | 0.90 |
| Alzheimer's Disease | drives | disease | 0.90 |
| Neuronal And Synaptic Loss | causes | phenotype | 0.90 |
| GFAP | biomarker_for | gene | 0.90 |
| ALZHEIMER'S DISEASE | biomarker_for | gene | 0.90 |
| Gliosis | associated_with | phenotype | 0.85 |
| Tauopathy | therapeutic_target | disease | 0.85 |
| Dementia | associated_with | disease | 0.85 |
| Inflammation | therapeutic_target | disease | 0.85 |
| Inflammation | associated_with | process | 0.85 |
| Alzheimer's Disease | biomarker_for | disease | 0.85 |
| Microgliosis | causes | process | 0.85 |
| Alzheimer'S Disease | contributes_to | disease | 0.85 |
| Neuroinflammation | activates | disease | 0.85 |
| Necroptosis | correlates_with | process | 0.85 |
| Dementia | biomarker_for | disease | 0.85 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER | associated_with | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| TAU | associated_with | gene | 1.00 |
| TAU | inhibits | gene | 1.00 |
| ALZHEIMER | therapeutic_target | gene | 1.00 |
| AMYLOID | associated_with | gene | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| TAU | activates | gene | 1.00 |
| TAU | regulates | gene | 1.00 |
| AMYLOID | activates | gene | 1.00 |
| Phosphorylated Tau 217 | biomarker_for | biomarker | 0.96 |
| mAb2A7 | associated_with | drug | 0.95 |
| APOE4 | promotes | protein | 0.95 |
| Lxr Agonist | suppresses | drug | 0.95 |
| Electroacupuncture | suppresses | drug | 0.95 |
| Plasma Ev Tau 3R/4R Ratio | biomarker_for | biomarker | 0.94 |
| P-Tau217 | biomarker_for | biomarker | 0.93 |
| Tau PET | biomarker_for | biomarker | 0.93 |
| Neuroinflammation | involved_in | process | 0.92 |
| PSEN1 | causes | gene | 0.92 |
| Tau Positron Emission Tomography | biomarker_for | biomarker | 0.91 |
| APOE4 | upregulates | gene | 0.90 |
| APOE | associated_with | protein | 0.90 |
| APOE | modulates | gene | 0.90 |
| LDLR | suppresses | gene | 0.90 |
| APOE4 | associated_with | protein | 0.90 |
| APOE-R136S | protects_against | protein | 0.90 |
| Oligodendrocytes | interacts_with | cell_type | 0.90 |
| Apoe4 | associated_with | protein | 0.90 |
| APOE | mediates | gene | 0.90 |
| autosomal dominant Alzheimer's Disease | causes | disease | 0.90 |
| Intermediate Filaments | interacts_with | protein | 0.90 |
| Necroptosis | correlates_with | process | 0.90 |
| RING-Bait | associated_with | drug | 0.90 |
| APOE4 | promotes | gene | 0.90 |
| Dazucorilant | treats | drug | 0.90 |
| Proteasomal Degradation | regulates | pathway | 0.90 |
| ABCA1 | suppresses | gene | 0.90 |
| Mab2A7 | associated_with | drug | 0.90 |
| proteasomal degradation | involved_in | process | 0.90 |
| BAG3 | protects_against | protein | 0.90 |
| NEURODEGENERATION | inhibits | gene | 0.90 |
| ALZHEIMER | biomarker_for | gene | 0.90 |
| AMYLOID | biomarker_for | gene | 0.90 |
| NEURODEGENERATION | activates | gene | 0.90 |
| BIN1 | associated_with | protein | 0.88 |
| BAG3 | protects_against | protein | 0.88 |
| Reactive Astrogliosis | associated_with | process | 0.88 |
| SST | associated_with | gene | 0.85 |
| Bispecific Antibodies | targets | drug | 0.85 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neuroscience | 2026-04-03 | 52 hypotheses Top: 1.000
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity